Enhanced Na+/H+ exchange in Cushing's syndrome reflects functional hypermineralocorticoidism

Journal of Hypertension

Volumn 16, Issue 8, 1998, Pages 1187-1191

  Koren, Wladimir ^a   Grienspuhn, Anatoly ^a   Kuznetsov, Sergei R ^b   Berezin, Meir ^a   Rosenthal, Talma ^a   Postnov, Yuvenali V ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

Author keywords

Erythrocytes; Hyperaldosteronism; Hypercortisolism; Sodium hydrogen exchange

Indexed keywords

ALDOSTERONE; AMILORIDE; CORTICOTROPIN; DEOXYCORTICOSTERONE; HYDROCORTISONE; SPIRONOLACTONE; TETRAHYDROCORTISOL;

ADRENAL CORTEX ADENOMA; ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL FEATURE; CUSHING SYNDROME; DIASTOLIC BLOOD PRESSURE; EDEMA; ELECTROLYTE BLOOD LEVEL; FEMALE; HUMAN; HYPERALDOSTERONISM; HYPERCORTISOLISM; HYPOPHYSIS ADENOMA; MALE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE;

EID: 0031826450     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816080-00012     Document Type: Article

References (12)

1. Rosskopf D, Duesing R, Siffert W. Membrane sodium-proton exchange and primary hypertension. Hypertension 1993; 21:607-617.
2. Canessa ML, Morgan K, Goldszer R, Moore TJ, Spalvins A. Kinetic abnormalities of the red blood cell sodium-proton exchange in hypertensive patients. Hypertension 1991; 17:340-348.
3. + exchange enhancement in primary aldosteronism. Am J Hypertens 1997, 10:341-345.
4. + exchange in red blood cells of patients with primary aldosteronism. Hypertension 1997; 29:587-591.
5. + exchange in arterial hypertension. In: Rosenthal T (editor): Hypertension in the Community, Proceedings of the IV Jerusalem Symposium, 1992. Israel: Israeli Academy of Sciences and Humanitites. p. 83.
6. Ulick S, Wang JZ, Blumenfeld JD, Pickering TG. Cortisol inactivation overload: a mechanism of mineralocorticoid hypertension in the ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 1992; 74:963-967.
7. + exchange and other ion-transporting systems in erythrocytes of essential hypertensives and spontaneously hypertensive rats: a comparative analysis. J Hypertens 1989; 7:781-788.
8. Mantero F, Palermo M, Petrelli MD, Tedde R, Stewart PM, Shackleton CH. Apparent mineralocorticoid excess: type I and type II. Steroids 1996; 61:193-196.
9. Stewart PM, Walker BR, Holder G, O'Halloran D, Shackleton CHL. 11 β-hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome. J Clin Endocrinol Metab 1995; 80:3617-3620.
10. Wehling M. Nongenomic aldosterone effects: the cell membrane as a specific target of mineralocorticoid action. Steroids 1995; 60:153-156.
11. Wehling M, Kasmayr J, Theisen K. Rapid effects of mineralocorticoids on sodium-proton exchanger: genomic or nongenomic pathway? Am J Physiol 1991; 260:E719-E726.
12. Christ M, Douwes K, Eisen C, Bechtner G, Theisen K, Wehling M. Rapid effects of aldosterone on sodium transport in vascular muscle cells. Hypertension 1995; 25:117-123.